Veterinary Medicines

Vitofyllin 50 mg film-coated tablets for dogs

Authorised
  • Propentofylline
Download as PDF

Product identification

Medicine name:
Vitofyllin 50 mg film-coated tablets for dogs
Vitofyllin 50 mg apvalkotās tabletes suņiem
Active substance:
  • Propentofylline
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Propentofylline
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC04AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Wirtschaftsgenossenschaft deutscher Tieraerzte eG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/SRP/23/0014
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0198/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 27/09/2022
Updated on: 14/03/2023
Download
Latvian (PDF)
Published on: 9/04/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."